Clinical utility of repurposing a short course of hepatitis C drugs for COVID19. A randomized controlled study

Mostafa Yakoot, Basem Eysa, Essam Gouda, Sherine A Helmy, Mahmoud R Elsayed, Ola Elrouby, Amal Mohamed, Ehab Reyad, Mohamed M Fawzi, Safaa Elmandouh, Wessam Abdellatif, Ahmed A Zidan, Abd-Elmoniem Adel, Mohamed Hassany
doi: https://doi.org/10.1101/2022.07.18.22277477

Article Information

doi 
https://doi.org/10.1101/2022.07.18.22277477
History 
  • July 18, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Mostafa Yakoot1,*,
  2. Basem Eysa2,
  3. Essam Gouda3,
  4. Sherine A Helmy4,
  5. Mahmoud R Elsayed3,
  6. Ola Elrouby4,
  7. Amal Mohamed2,
  8. Ehab Reyad2,
  9. Mohamed M Fawzi2,
  10. Safaa Elmandouh2,
  11. Wessam Abdellatif2,
  12. Ahmed A Zidan2,
  13. Abd-Elmoniem Adel2 and
  14. Mohamed Hassany2
  1. 1Green Clinic and Research Centre, Alexandria University, Egypt
  2. 2The National Hepatology and Tropical Medicine Research Institute (NHTMRI), Cairo, Egypt
  3. 3Chest Diseases Department, Alexandria Faculty of Medicine, Alexandria, Egypt
  4. 4Pharco Corporate, Alexandria, Egypt
  1. ↵*CORRESPONDING AUTHOR:
    Mostafa Yakoot; Green Clinic and Research Center, Alexandria 21121, Egypt, Mobile: +201223927561 yakoot{at}yahoo.com
Back to top
Posted July 18, 2022.
Download PDF
Data/Code
Email
Clinical utility of repurposing a short course of hepatitis C drugs for COVID19. A randomized controlled study
Mostafa Yakoot, Basem Eysa, Essam Gouda, Sherine A Helmy, Mahmoud R Elsayed, Ola Elrouby, Amal Mohamed, Ehab Reyad, Mohamed M Fawzi, Safaa Elmandouh, Wessam Abdellatif, Ahmed A Zidan, Abd-Elmoniem Adel, Mohamed Hassany
medRxiv 2022.07.18.22277477; doi: https://doi.org/10.1101/2022.07.18.22277477
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area